A team led by VA researchers Dr. Amy Justice and Dr. Christopher Rentsch found that race and ethnicity is associated with a greater risk of testing positive for COVID-19 – but not death – within a 30-day period after hospital discharge. Justice is a clinical epidemiologist at the West Haven VA Medical Center in Connecticut and Yale University. The study was published in PLOS Medicine on Sept. 22.

The investigators analyzed the electronic health records of 5.8 million Veterans in VA care. Within that group, 254,595 people were tested for COVID-19 between Feb. 8 and July 22, 2020; of those, 16,317 tested positive and 1,057 died.

Reducing spread of COVID-19 among minorities

The team found a substantial excess burden of COVID-19 infection in minority communities. They identified an urgent need to develop state- and local-level strategies to reduce COVID-19 spread in minority groups.

“Black and Hispanic individuals were twice as likely to test positive for COVID-19, even after accounting for underlying health conditions, other demographics, and geographic location,” said lead author Dr. Christopher Rentsch, who is also an assistant professor at the London School of Hygiene and Tropical Medicine in the United Kingdom.

Using data analytics to identify health disparities

The study is the first to look at patterns of testing for SARS-CoV-2, wrote the authors, rather than focus just on patients who had tested positive for COVID-19 or were hospitalized because of the novel coronavirus.

The research team was composed of investigators from VA Connecticut Healthcare System, VA Palo Alto Health Care System, VA Puget Sound Health Care System, VA Tennessee Valley Healthcare System, and several other research institutions.

They found that Black and Hispanic Veterans were twice as likely to test positive for COVID-19, compared with their white counterparts. The finding held true even after the researchers accounted for underlying health conditions geographic location, and other demographic factors. However, 30-day mortality (death) rates among infected patients did not differ by race or ethnicity.

VA's study on COVID-19 could help strengthen response strategies related to racial and ethnic disparities. (Photo courtesy of London School of Hygiene and Tropical Medicine.)

VA’s study on COVID-19 could help strengthen response strategies related to racial and ethnic disparities. (Photo courtesy of London School of Hygiene and Tropical Medicine.)

Reasons for disparities not clear

More than 250,000 individuals were tested for COVID-19 during the study period; of those, 4.4% of white Veterans were positive for COVID-19, 10.2% of Blacks were positive, and 11.4% of Hispanics were positive. The racial breakdown of study participants who tested positive was 43.9% white, 40.4% Black, and 15.7% Hispanic.

The researchers also found that Black Veterans were more likely to be tested for SARS-CoV-2 than Hispanic or white Veterans. The reason for the increased testing rate among Black Veterans was not clear.

Regional differences in disease incidence

The team was not fully able to explain the reasons behind racial disparities in COVID-19 infection. While 66% of all individuals in the study population lived in urban areas, 87% of those who tested positive were urban residents. Previous studies have found that members of minority groups are more likely to live in high-density cities or multigenerational households where the risk of COVID-19 infection is greater. They are also more likely to work in essential industries, such as public transportation, where the chance of contact with the public is increased.

The researchers also found regional differences in disease incidence between Black and white Veterans. COVID-19 disparities for positive test rates in Black Veterans were highest in the Midwest region and lowest in the West. Disparities between the two groups decreased slightly over the study period. The disparity between Hispanic and white Veterans who tested positive was consistent across time, region, and outbreak patterns.

More Information

Click here to read the full story.

Click here to learn more about VA research on COVID-19.

Click here to read more about VA research.

Drs. Michelle Estrella and Michael Shlipak of the San Francisco VA believe the cystatin C test is much more accurate in detecting kidney disease than the one that has long been used in standard medical practice, the creatinine test. Here, they are working with a machine that measures both tests.VA researchers striving to improve detection of kidney disease
Doctor treats Alzheimer’s patient with brain stimulation.Brain stimulation for Alzheimer’s on the horizon?

Share This Story, Choose Your Platform!